Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2max ) of >180 Gy for patients with recurrent head and neck cancer.
Jens von der GrünJanett KöhnBritta Loutfi-KraussOliver BlanckClaus RödelPanagiotis BalermpasPublished in: Head & neck (2018)
These cases show that a second course of re-irradiation utilizing modern techniques like robotic radiosurgery might be feasible for carefully selected patients with head and neck cancer.